Navigation Links
VaxGen and Raven Announce Form S4 Registration Statement Declared Effective

term objectives,

including preparation for the start of Phase 2 clinical trials for its

lead product RAV12 as well as the advancement of two IND candidates.

-- The Companies have established transition and integration plans and

teams as they relate to information technology, human resource

policies, financial systems and reporting and Sarbanes-Oxley


-- A number of VaxGen scientists are now working on Raven projects under

arms-length contractual arrangements. These arrangements serve to

advance critical R&D projects and are expected to facilitate the post-

close integration process.

-- The companies have determined that dedicating the use of the VaxGen

manufacturing facility to the Raven pipeline over the next two to

three years is not the most economically attractive option, and

therefore divestment or partnering of the facility is being actively


"Our goal for the merged company is to focus on advancing our pipeline of monoclonal antibodies directed against cancer stem cells, and these actions will allow us to do this in what we believe will be the most cost-effective manner possible," said George F. Schreiner, M.D., Ph.D., Raven's Chief Executive Officer. "We are confident that this merger will provide value to investors and, subject to a positive stockholder vote and satisfaction of the closing conditions, we look forward to combining our two companies."

About VaxGen

VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. For more information, please visit the company's web site at

About Raven


SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. VaxGen Files 2006 Financial Statements and Provides Cash Update
2. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
3. VaxGen Files First Quarter 2007 Financials
4. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
5. VaxGen Files Last Outstanding Periodic Report With SEC
6. VaxGen Addresses MPM Claims in Letter to Stockholders
7. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
8. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
9. Positive Outcome of Drug-Drug Interaction Trial With Intravenous Iclaprim
10. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
11. First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
Post Your Comments:
(Date:8/27/2014)... Aug. 27, 2014 has added ... Graphene Opportunity - A Rational View ... New Nanotech? A similar amount of hype ... ranging from microelectronics to water treatment, but is ... availability of the Graphene Opportunity Report, authored by ...
(Date:8/27/2014)... , Aug. 27, 2014  ARCH Venture Partners, ... investing in the development of seed and early-stage ... venture fund closed with more than $400 million ... $250 million subscription target by more than $150 ... shows the strength and potential of our approach ...
(Date:8/27/2014)... White City, OR (PRWEB) August 27, 2014 ... it stands to reason that the next beverage craze ... Force Technology announced today that formulators can use Stress ... any ingredient used in the making of a beverage, ... natural release for stress-generated energy, channeling that power into ...
(Date:8/27/2014)... Budding Biomedical Scientists , This ... participated in the Scientific Enrichment and Opportunity ... of Medicine . , The rigorous ... experience in the sciences and brings them in ... students for both academic and career mentoring. , ...
Breaking Biology Technology:The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2
... , NEW YORK, Sept. 8 announces that a ... Nanomedicine , , ... This report analyzes the Global Market for Nanomedicine in Millions of US$ ... Imaging, Biomaterials, and Others. Annual forecasts are provided for the period of ...
... , ATLANTA and BRIDGEWATER, N.J. Sept. 8 From ... this year,s back to school they should also prepare for the upcoming ... new school year, the My Xperts(TM) program, created by UCB and sanofi-aventis ... outdoor nasal allergy experts to help parents prepare for fall allergy season ...
... ... , ... September 8, 2009 -- Ensuring food security for a growing world population is a ... that involves novel approaches and techniques to meet future demands, William S. Niebur ...
Cached Biology Technology:Reportlinker Adds Nanomedicine Report 2Reportlinker Adds Nanomedicine Report 3Reportlinker Adds Nanomedicine Report 4Reportlinker Adds Nanomedicine Report 5Reportlinker Adds Nanomedicine Report 6Reportlinker Adds Nanomedicine Report 7Reportlinker Adds Nanomedicine Report 8Reportlinker Adds Nanomedicine Report 9Reportlinker Adds Nanomedicine Report 10Reportlinker Adds Nanomedicine Report 11VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 2VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 3VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 4VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 5VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 6DuPont Leader Says Increasing Food Production a Moral Imperative 2DuPont Leader Says Increasing Food Production a Moral Imperative 3
(Date:8/27/2014)... cells to rearrange existing patterns of activity than when ... study of monkeys has found. The scientists explored the ... of brain cell networks. The study was partly funded ... into the brain and may have seen why it,s ... Batista, Ph.D., an assistant professor at the University of ...
(Date:8/27/2014)... want to listen carefully to someone, the first thing ... do is stop moving altogether. This strategy helps us ... own movements. , This interplay between movement and hearing ... indirect evidence has long suggested that the brain,s motor ... which gives rise to our conscious perception of sound. ...
(Date:8/27/2014)... in German . ... common inherited disease affecting the peripheral nervous system. Researchers ... Institute of Experimental Medicine and University Medical Centre Gttingen ... impaired in rats with the disease. These cells enwrap ... myelin, which facilitates the rapid transfer of electrical impulses. ...
Breaking Biology News(10 mins):Scientists plug into a learning brain 2Scientists plug into a learning brain 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
... that prevents the body from using stored sugar has survived ... at the University of Florida putting scientists a step ... Called glycogen storage disease type 1A, the genetic disease ... use sugar between meals. In order to survive, children and ...
... Francisco, and collaborators at Harvard Medical School have linked ... that clears glucose out of the bloodstream, shedding light ... a cellular level. Establishing the function ... mice, has broad implications for both the future study ...
... for Cancer Research at the University of California, San ... of the contractile ring, a structure required for cell ... divide the cell may facilitate development of therapies to ... researchers show that even though both cell volume ...
Cached Biology News:UF makes gene therapy advance in severe genetic disorder 2UF makes gene therapy advance in severe genetic disorder 3UCSF discovers new glucose-regulating protein linked with diabetes 2Study may aid efforts to prevent uncontrolled cell division in cancer 2
... Best: DASGIPs Process Control integrates Process ... comprehensive documentation for cultivation processes. A ... pH, dissolved oxygen, temperature and agitation ... Profiles, e.g. constant or scheduled media ...
... LC Sciences provides a genome-wide microRNA ... and proprietary probe design, which enable highly ... (1-3). We have standard arrays for mature ... latest version of the Sanger miRBase database ...
... synthetic peptide whose sequences are derived from mouse resistin protein. ... - S - M - P - L - C - ... - D - K - K - I - K - ... used for neutralization and control experiments with the polyclonal antibody that ...
... Imaging System, Basic Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... for both proteomic and general life science ... enabling the use of all dyes in ...
Biology Products: